MRI contrast-dose relationship of manganese(III)tetra(4-sulfonatophenyl) porphyrin with human xenograft tumors in nude mice at 2.0 T
- 31 December 1992
- journal article
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 10 (6) , 919-928
- https://doi.org/10.1016/0730-725x(92)90446-7
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A comparative study of manganese meso-sulfonatophenyl porphyrins: Contrast-enhancing agents for tumorsMagnetic Resonance Imaging, 1990
- Proton relaxation enhancement in experimental brain tumors—In vivo NMR study of manganese(III)TPPS in rat brain gliomasMagnetic Resonance Imaging, 1990
- Isointense model for the evaluation of tumor-specific MRI contrast agentsMagnetic Resonance Imaging, 1988
- Mechanism of the localization of manganese (III) mesotetra(4-sulfonatophenyl)porphine i in mice bearing L1210 tumorsCancer Letters, 1988
- The anomalous relaxivity of Mn3+(TPPS4)Magnetic Resonance in Medicine, 1987
- Tissue distribution and stability of metalloporphyrin MRI contrast agentsMagnetic Resonance in Medicine, 1987
- Proton relaxation enhancement by manganese(III)TPPS4 in a model tumor systemMagnetic Resonance Imaging, 1987
- Manganese Protoporphyrin IXInvestigative Radiology, 1985
- Paramagnetic metalloporphyrins as potential contrast agents in NMR imagingFEBS Letters, 1984
- The distribution of various water soluble radioactive metalloporphyrins in tumor bearing miceBioinorganic Chemistry, 1975